Biomarkers in DILI: one more step forward

• Egile Nagusiak: Mercedes Robles-Díaz (Egilea), Inmaculada Medina-Caliz (Egilea), Camilla Stephens (Egilea), Raúl J Andrade (Egilea), M Isabel Lucena (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2016-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Despite being relatively rare, drug-induced liver injury (DILI) is a serious condition, both for the individual patient due to the risk of acute liver failure, and for the drug development industry and regulatory agencies due to associations with drug development attritions, black box warnings and p...